Your browser doesn't support javascript.
loading
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.
Liu, Yin; Zhu, Xiu-Zhi; Xiao, Yi; Wu, Song-Yang; Zuo, Wen-Jia; Yu, Qiang; Cao, A-Yong; Li, Jun-Jie; Yu, Ke-Da; Liu, Guang-Yu; Wu, Jiong; Sun, Tao; Cui, Jiu-Wei; Lv, Zheng; Li, Hui-Ping; Zhu, Xiao-Yu; Jiang, Yi-Zhou; Wang, Zhong-Hua; Shao, Zhi-Ming.
Affiliation
  • Liu Y; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhu XZ; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xiao Y; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wu SY; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zuo WJ; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Yu Q; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Cao AY; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li JJ; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yu KD; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Liu GY; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wu J; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Sun T; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Cui JW; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Lv Z; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li HP; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhu XY; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Jiang YZ; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wang ZH; Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Shao ZM; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Cell Res ; 33(5): 389-402, 2023 05.
Article in En | MEDLINE | ID: mdl-36973538
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Res Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Res Year: 2023 Document type: Article Affiliation country: Country of publication: